ISoP 2017: Pharmacovigilance in the 21st Century - Innovation for Patient Benefit
|Type||Public / Private|
The International Society of Pharmacovigilance (ISoP) is a professional, independent and a non-profit society that is open to anyone with an interest in the safe and effective use of medicinal products.
The 17th Annual Meeting of the International Society of Pharmacovigilance (ISOP) will take place from the 15-18th October 2017 in Liverpool with the theme “Pharmacovigilance in the 21st Century – Innovation for Patient Benefit”. It is going to be a great opportunity to learn about the latest trends in pharmacovigilance and to discuss about the challenges of social media and drug safety and how they can be used for the benefit of the patient.
ISOP’s main aim is ‘to foster science and learning in pharmacovigilance in all countries’, this is achieved by providing the following:
- Opportunities for networking in a friendly environment
- Collegial and convivial support among fellow pharmacovigilance professionals
- An open and impartial forum for sharing experience and knowledge
- A platform for discussion and generation of new research and ideas
- Meetings, education and affordable training
The pre-conference programme will take place on Sunday 15th October at the ACC, Liverpool. The conference topics include:
- Pediatric Pharmacovigilance:
This course will present the current Pharmacovigilance approach for the monitoring of drug safety in children, covering the issues raised above, as well as providing an overview of the state of the art from clinical trials to observational studies and spontaneous reporting.
- Pharmacovigilance and Social Media:
This course is aimed to stimulate the discussion on how monitoring social media with practical experience from different pharmacovigilance stakeholders. This training course will provide knowledge to improve social media periodic screening for safety information in routine office practice in a pharmaceutical industry and/or in a regulatory agency.
The presentations will focus on the following topics of pharmacovigilance and drug safety:
• Health Data Science
• Social Media, electronic media and Pharmacovigilance
• Big data approaches in pharmacovigilance
• Drug-induced organ specific injury (liver, skin, kidneys and other organs)
• Clinical approaches in risk management
• Herbal pharmacovigilance
• Advanced cell therapies and pharmacovigilance
• Pharmacovigilance in Oncology
• Biologics, biosimilars and pharmacovigilance
• Pharmacogenomics and pharmacovigilance
• Women’s Health
Top 5 Recent Tweets